The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
The facility is a part of Lupin Manufacturing Solutions
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
These observations are procedural in nature and will be responded within the stipulated time
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Subscribe To Our Newsletter & Stay Updated
